Ashutosh Dash

5.1k total citations
284 papers, 4.0k citations indexed

About

Ashutosh Dash is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ashutosh Dash has authored 284 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 193 papers in Radiology, Nuclear Medicine and Imaging, 66 papers in Pulmonary and Respiratory Medicine and 59 papers in Oncology. Recurrent topics in Ashutosh Dash's work include Radiopharmaceutical Chemistry and Applications (175 papers), Medical Imaging Techniques and Applications (68 papers) and Peptidase Inhibition and Analysis (29 papers). Ashutosh Dash is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (175 papers), Medical Imaging Techniques and Applications (68 papers) and Peptidase Inhibition and Analysis (29 papers). Ashutosh Dash collaborates with scholars based in India, United States and Austria. Ashutosh Dash's co-authors include Rubel Chakravarty, M.R.A. Pillai, F. F. Knapp, Sudipta Chakraborty, Haladhar Dev Sarma, Meera Venkatesh, Ramu Ram, Usha Pandey, Rakesh Shukla and K.V. Vimalnath and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Journal of Hazardous Materials.

In The Last Decade

Ashutosh Dash

273 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashutosh Dash India 31 2.4k 794 629 617 521 284 4.0k
Saed Mirzadeh United States 39 2.9k 1.2× 1.0k 1.3× 475 0.8× 874 1.4× 656 1.3× 126 4.3k
Rubel Chakravarty India 29 1.7k 0.7× 497 0.6× 357 0.6× 514 0.8× 250 0.5× 140 2.6k
M.R.A. Pillai India 29 2.1k 0.9× 942 1.2× 611 1.0× 350 0.6× 292 0.6× 102 2.9k
Sudipta Chakraborty India 28 1.8k 0.8× 720 0.9× 633 1.0× 358 0.6× 221 0.4× 175 2.7k
Suzanne E. Lapi United States 32 1.8k 0.8× 645 0.8× 756 1.2× 236 0.4× 287 0.6× 194 3.2k
Cristina Müller Switzerland 49 4.2k 1.8× 2.0k 2.5× 1.7k 2.7× 430 0.7× 464 0.9× 163 6.3k
Aleksander Bilewicz Poland 27 1.1k 0.5× 559 0.7× 182 0.3× 345 0.6× 195 0.4× 102 1.9k
Alun G. Jones United States 37 2.7k 1.1× 698 0.9× 1.1k 1.8× 747 1.2× 115 0.2× 162 4.6k
Minoru Suzuki Japan 46 4.2k 1.8× 1.4k 1.8× 572 0.9× 2.3k 3.8× 1.8k 3.4× 476 8.8k
Michael R. McDevitt United States 45 4.6k 1.9× 2.0k 2.6× 1.6k 2.6× 1.0k 1.7× 694 1.3× 113 7.8k

Countries citing papers authored by Ashutosh Dash

Since Specialization
Citations

This map shows the geographic impact of Ashutosh Dash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashutosh Dash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashutosh Dash more than expected).

Fields of papers citing papers by Ashutosh Dash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashutosh Dash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashutosh Dash. The network helps show where Ashutosh Dash may publish in the future.

Co-authorship network of co-authors of Ashutosh Dash

This figure shows the co-authorship network connecting the top 25 collaborators of Ashutosh Dash. A scholar is included among the top collaborators of Ashutosh Dash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashutosh Dash. Ashutosh Dash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Rohit, et al.. (2020). Comparative In Vitro Cytotoxicity Studies of 177 Lu-CHX-A″-DTPA-Trastuzumab and 177 Lu-CHX-A″-DTPA-F(ab′) 2 -Trastuzumab in HER2-Positive Cancer Cell Lines. Cancer Biotherapy and Radiopharmaceuticals. 35(3). 177–189. 6 indexed citations
2.
Pandey, Usha, et al.. (2019). Synthesis and Preliminary Biological Evaluation of 177 Lu-Labeled Polyhydroxamic Acid Microparticles Toward Therapy of Hepatocellular Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 34(5). 306–315. 3 indexed citations
3.
Ghosh, Subhajit, Tapas Das, Haladhar Dev Sarma, & Ashutosh Dash. (2018). The potential of radiolabeled chemotherapeutics in tumor diagnosis: Preliminary investigations with 68Ga‐gemcitabine. Drug Development Research. 79(3). 111–118. 2 indexed citations
4.
Chakraborty, Sudipta, K.V. Vimalnath, Rubel Chakravarty, Haladhar Dev Sarma, & Ashutosh Dash. (2018). Multidose formulation of ready-to-use 177Lu-PSMA-617 in a centralized radiopharmacy set-up. Applied Radiation and Isotopes. 139. 91–97. 12 indexed citations
5.
Kumar, M., et al.. (2018). Utilization of Chemical Deposition Technique for Preparation of Miniature 170 Tm Sources and Preliminary Quality Assessment for Potential Use in Brachytherapy. Cancer Biotherapy and Radiopharmaceuticals. 34(1). 24–32. 3 indexed citations
6.
7.
Das, Tapas, et al.. (2017). Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study. Anti-Cancer Agents in Medicinal Chemistry. 18(1). 146–153. 16 indexed citations
8.
Ghosh, Subhajit, Tapas Das, Haladhar Dev Sarma, & Ashutosh Dash. (2017). Preparation and Evaluation of 177 Lu-Labeled Gemcitabine: An Effort Toward Developing Radiolabeled Chemotherapeutics for Targeted Therapy Applications. Cancer Biotherapy and Radiopharmaceuticals. 32(7). 239–246. 4 indexed citations
9.
Pandey, Usha, et al.. (2017). Preparation of Radioactive Skin Patches Using Polyhydroxamic Acid-Grafted Cellulose Films Toward Applications in Treatment of Superficial Tumors. Cancer Biotherapy and Radiopharmaceuticals. 32(10). 364–370. 3 indexed citations
10.
Mathur, Anupam, Sudipta Chakraborty, K.V. Vimalnath, et al.. (2017). Bulk Scale Formulation of Therapeutic Doses of Clinical Grade Ready-to-Use 177 Lu-DOTA-TATE: The Intricate Radiochemistry Aspects. Cancer Biotherapy and Radiopharmaceuticals. 32(7). 266–273. 6 indexed citations
11.
Gota, Vikram, et al.. (2016). Preparation and preclinical evaluation of 131I‐trastuzumab for breast cancer. Journal of Labelled Compounds and Radiopharmaceuticals. 60(1). 12–19. 16 indexed citations
12.
Dash, Ashutosh, Sudipta Chakraborty, M.R.A. Pillai, & F. F. Knapp. (2015). Peptide Receptor Radionuclide Therapy: An Overview. Cancer Biotherapy and Radiopharmaceuticals. 30(2). 47–71. 96 indexed citations
13.
Pandey, Usha, et al.. (2015). Synthesis and Preclinical Evaluation of 177 Lu-CHX-A”-DTPA-Rituximab as a Radioimmunotherapeutic Agent for Non-Hodgkin's Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 30(6). 240–246. 18 indexed citations
14.
Pandey, Usha, et al.. (2014). On the Application of Nafion Membrane for the Preparation of 90 Y Skin Patches, Quality Control, and Biological Evaluation for Treatment of Superficial Tumors. Cancer Biotherapy and Radiopharmaceuticals. 29(5). 200–209. 1 indexed citations
15.
Das, Tapas, Haladhar Dev Sarma, Rubel Chakravarty, et al.. (2013). Synthesis and Biological Evaluation of 90 Y-Labeled Porphyrin-DOTA Conjugate: A Potential Molecule for Targeted Tumor Therapy. Cancer Biotherapy and Radiopharmaceuticals. 28(9). 651–656. 17 indexed citations
16.
Dash, Ashutosh, F.F. Knapp, & M. Radhakrishna Pillai. (2013). Targeted Radionuclide Therapy - An Overview. Current Radiopharmaceuticals. 6(3). 152–180. 85 indexed citations
17.
Kumar, Yogendra, et al.. (2012). Nafion–Zirconium Phosphate Composite Membrane: A New Approach to Prepare 32 P Patches for Superficial Brachytherapy Applications. Cancer Biotherapy and Radiopharmaceuticals. 27(4). 276–284. 7 indexed citations
18.
Chakraborty, Sudipta, Rubel Chakravarty, Haladhar Dev Sarma, Ashutosh Dash, & M.R.A. Pillai. (2012). The Practicality of Nanoceria-PAN-Based 68 Ge/ 68 Ga Generator Toward Preparation of 68 Ga-Labeled Cyclic RGD Dimer as a Potential PET Radiotracer for Tumor Imaging. Cancer Biotherapy and Radiopharmaceuticals. 28(1). 77–83. 19 indexed citations
19.
Chakravarty, Rubel & Ashutosh Dash. (2012). Availability of Yttrium-90 from Strontium-90: A Nuclear Medicine Perspective. Cancer Biotherapy and Radiopharmaceuticals. 27(10). 621–641. 71 indexed citations
20.
Dash, Ashutosh, et al.. (2009). Fabrication of Cesium-137 Brachytherapy Sources Using Vitrification Technology. Cancer Biotherapy and Radiopharmaceuticals. 24(4). 489–502. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026